The September 2026 mistrial, declared after a jury deadlocked 11-1 in favor of acquitting Lindsay Clancy on first-degree murder charges tied to her postpartum psychosis defense, stands as the dominant factor shaping trader sentiment. With prosecutors yet to confirm a retrial and Clancy remaining at Tewksbury State Hospital, market-implied odds for any conviction by year-end sit very low, reflecting the holdout juror’s impact and broader uncertainty around double-jeopardy arguments. The October denial of a defense motion for a directed acquittal keeps the case alive but does little to shift consensus. Traders are watching the November 2 status hearing for signals on whether Plymouth County DA Timothy Cruz will pursue lesser charges, drop the case, or set a new trial date, as these outcomes will directly influence resolution before the December 31 deadline.